Creating a device to quickly detect SARS-CoV-2 in the air
Official title: Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time
Funded at Genendeavor, LLC · NIH-10854070 · Data updated 2026-11-12
This study is working on a handy device that can quickly check the air for COVID-19 particles, helping people understand and manage the virus as we get back to our daily lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Genendeavor, LLC NIH-funded |
| Lab location | 1 site (Hayward, UNITED STATES) |
| Project start | June 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $1,781,288 |
| NIH project number | 3R01DE031927-01S1 |
| Project ID | NIH-10854070 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals in community settings, workplaces, and schools who are concerned about airborne transmission of COVID-19.
✕Less likely to help
Patients who are not in environments where aerosol transmission is a concern may not benefit from this research.
What this research studies
This research focuses on developing a handheld device that can monitor and quantify the presence of SARS-CoV-2 in aerosol particles in real-time. By utilizing advanced technologies such as rapid-kinetic chemical auto-ligation and solid-state electronics, the device aims to provide immediate results without the need for complex laboratory equipment. This capability is crucial for understanding and managing the airborne transmission of COVID-19 as communities return to normal activities. The project combines expertise from various fields to create a novel air monitoring system that could transform how we study and respond to the virus.
Why it matters
Potential benefit: If successful, this research could lead to a significant advancement in public health by enabling real-time monitoring of COVID-19 transmission risks in various environments.
How similar studies have gone: While there have been advancements in air monitoring technologies, this specific approach to real-time detection of SARS-CoV-2 in aerosols is novel and has not been extensively tested.
Where this research is happening
-
Genendeavor, LLC
Hayward, United States Active
Researchers
- Principal investigator: Mancebo, Ricardo — Genendeavor, LLC
- Study coordinator: Mancebo, Ricardo
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.